Terms: = Liver cancer AND CYLD, CYLD1, 1540, ENSG00000083799, USPL2, KIAA0849, CYLDI, CDMT, HSPC057, FLJ31664, FLJ20180, EAC AND Treatment
55 results:
1. Clinicopathological, metastatic and prognostic features of stage IV esophageal adenocarcinoma versus squamous cell carcinoma: a SEER database analysis.
Pan L; Zhang Y; Gao Y; Qiu J
Chin Clin Oncol; 2024 Feb; 13(1):2. PubMed ID: 38372056
[TBL] [Abstract] [Full Text] [Related]
2. Prediction model of ocular metastasis from primary liver cancer: Machine learning-based development and interpretation study.
Sun JQ; Wu SN; Mou ZL; Wen JY; Wei H; Zou J; Li QJ; Liu ZL; Xu SH; Kang M; Ling Q; Huang H; Chen X; Wang YX; Liao XL; Tan G; Shao Y
Cancer Med; 2023 Oct; 12(20):20482-20496. PubMed ID: 37795569
[TBL] [Abstract] [Full Text] [Related]
3. Reflux conditions induce E-cadherin cleavage and EMT via APE1 redox function in oesophageal adenocarcinoma.
Lu H; Cao LL; Ballout F; Belkhiri A; Peng D; Chen L; Chen Z; Soutto M; Wang TC; Que J; Giordano S; Washington MK; Chen S; McDonald OG; Zaika A; El-Rifai W
Gut; 2023 Dec; 73(1):47-62. PubMed ID: 37734913
[TBL] [Abstract] [Full Text] [Related]
4. Age-dependent benefit of neoadjuvant treatment in adenocarcinoma of the esophagus and gastroesophageal junction: a multicenter retrospective observational study of young versus old patients.
Rompen IF; Crnovrsanin N; Nienhüser H; Neuschütz K; Fourie L; Sisic L; Müller-Stich BP; Billeter AT
Int J Surg; 2023 Dec; 109(12):3804-3814. PubMed ID: 37720939
[TBL] [Abstract] [Full Text] [Related]
5. The Effect of Iron Oxide Nanoparticles of
Moustafa AMY; Abd El-Hamid El-Damrany MM; Youssef MM
Anticancer Agents Med Chem; 2023; 23(14):1652-1669. PubMed ID: 37198986
[TBL] [Abstract] [Full Text] [Related]
6. Anticancer potential of
Nagavani V; Raghavarao T
J Cancer Res Ther; 2023 Apr; 19(Supplement):S241-S249. PubMed ID: 37148001
[TBL] [Abstract] [Full Text] [Related]
7. Circulating exosomal immuno-oncological checkpoints and cytokines are potential biomarkers to monitor tumor response to anti-PD-1/PD-L1 therapy in non-small cell lung cancer patients.
Akbar S; Raza A; Mohsin R; Kanbour A; Qadri S; Parray A; Zar Gul AR; Philip A; Vijayakumar S; Merhi M; Hydrose S; Inchakalody VP; Al-Abdulla R; Abualainin W; Sirriya SA; Al-Bozom I; Uddin S; Khan OM; Mohamed Ibrahim MI; Al Homsi U; Dermime S
Front Immunol; 2022; 13():1097117. PubMed ID: 36741391
[TBL] [Abstract] [Full Text] [Related]
8. Roles of Nuclear Receptors in Esophageal cancer.
Deng L; Liu J; Chen WD; Wang YD
Curr Pharm Biotechnol; 2023; 24(12):1489-1503. PubMed ID: 36740804
[TBL] [Abstract] [Full Text] [Related]
9. Clinical Predictor of Urinary Protein as Adverse Event Associated with Atezolizumab plus Bevacizumab treatment for Unresectable Hepatocellular Carcinoma.
Hiraoka A; Kumada T; Tada T; Hirooka M; Kariyama K; Tani J; Atsukawa M; Takaguchi K; Itobayashi E; Fukunishi S; Tsuji K; Ishikawa T; Tajiri K; Ochi H; Yasuda S; Toyoda H; Ogawa C; Nishimura T; Hatanaka T; Kakizaki S; Shimada N; Kawata K; Naganuma A; Kosaka H; Ohama H; Tada F; Nouso K; Morishita A; Tsutsui A; Nagano T; Itokawa N; Okubo T; Arai T; Imai M; Koizumi Y; Nakamura S; Iijima H; Kaibori M; Hiasa Y; Kudo M; ;
Oncology; 2022; 100(12):645-654. PubMed ID: 36103846
[TBL] [Abstract] [Full Text] [Related]
10. Pitavastatin-loaded bilosomes for oral treatment of hepatocellular carcinoma: a repurposing approach.
Kharouba M; El-Kamel A; Mehanna R; Thabet E; Heikal L
Drug Deliv; 2022 Dec; 29(1):2925-2944. PubMed ID: 36081339
[TBL] [Abstract] [Full Text] [Related]
11. FOLFIRINOX or gemcitabine/nab-paclitaxel in advanced pancreatic adenocarcinoma: A novel validated prognostic score to facilitate treatment decision-making in real-world.
Marschner N; Hegewisch-Becker S; Reiser M; von der Heyde E; Bertram M; Hollerbach SH; Kreher S; Wolf T; Binninger A; Chiabudini M; Kaiser-Osterhues A; Jänicke M;
Int J Cancer; 2023 Feb; 152(3):458-469. PubMed ID: 36053905
[TBL] [Abstract] [Full Text] [Related]
12. Circulating Hybrid Cells: A Novel Liquid Biomarker of treatment Response in Gastrointestinal cancers.
Walker BS; Sutton TL; Zarour L; Hunter JG; Wood SG; Tsikitis VL; Herzig DO; Lopez CD; Chen EY; Mayo SC; Wong MH
Ann Surg Oncol; 2021 Dec; 28(13):8567-8578. PubMed ID: 34365557
[TBL] [Abstract] [Full Text] [Related]
13. [Safety and effectiveness of oxaliplatin combined with capecitabine or oxaliplatin combined with S-1 neoadjuvant chemotherapy in the treatment of advanced gastric cancer].
Xie BW; Zang L; Ma JJ; Sun J; Yang X; Wang ML; Lu AG; Hu WG; Zheng MH
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):138-144. PubMed ID: 33508919
[No Abstract] [Full Text] [Related]
14. Anti-Metastatic Potential of a Novel Xanthone Sourced by Swertia chirata Against In Vivo and In Vitro Breast Adenocarcinoma Frameworks.
Barua A; Choudhury P; Mandal S; Panda CK; Saha P
Asian Pac J Cancer Prev; 2020 Oct; 21(10):2865-2875. PubMed ID: 33112542
[TBL] [Abstract] [Full Text] [Related]
15. Confocal Laser Endomicroscopy vs Biopsies in the Assessment of Persistent or Recurrent Intestinal Metaplasia/Neoplasia after Endoscopic treatment of Barrett's Esophagus related Neoplasia.
Krajciova J; Kollar M; Maluskova J; Janicko M; Vackova Z; Spicak J; Martinek J
J Gastrointestin Liver Dis; 2020 Sep; 29(3):305-312. PubMed ID: 32919414
[TBL] [Abstract] [Full Text] [Related]
16. Triaryl dicationic DNA minor-groove binders with antioxidant activity display cytotoxicity and induce apoptosis in breast cancer.
Nafie MS; Arafa K; Sedky NK; Alakhdar AA; Arafa RK
Chem Biol Interact; 2020 Jun; 324():109087. PubMed ID: 32294457
[TBL] [Abstract] [Full Text] [Related]
17. Bisdemethoxycurcumin Inhibits Hepatocellular Carcinoma Proliferation Through Akt Inactivation via cyld-Mediated Deubiquitination.
Qiu C; Liu K; Zhang S; Gao S; Chen W; Li D; Huang Y
Drug Des Devel Ther; 2020; 14():993-1001. PubMed ID: 32184568
[TBL] [Abstract] [Full Text] [Related]
18. Outcomes of patients with submucosal (T1b) esophageal adenocarcinoma: a multicenter cohort study.
Otaki F; Ma GK; Krigel A; Dierkhising RA; Lewis JT; Blevins CH; Gopalakrishnan NP; Ravindran A; Johnson ML; Leggett CL; Wigle D; Wang KK; Falk GW; Abrams JA; Nakagawa H; Rustgi AK; Wang TC; Lightdale CJ; Ginsberg GG; Iyer PG
Gastrointest Endosc; 2020 Jul; 92(1):31-39.e1. PubMed ID: 31953189
[TBL] [Abstract] [Full Text] [Related]
19. Radiofrequency Ablation in Patients with Barrett's Esophagus- related Neoplasia - Long-Term Outcomes in the Czech National Database.
Krajciova J; Janicko M; Falt P; Gregar J; Suchanek S; Ngo O; Kollar M; Urban O; Prochazka V; Zavoral M; Spicak J; Martinek J
J Gastrointestin Liver Dis; 2019 Jun; 28():149-155. PubMed ID: 31204400
[TBL] [Abstract] [Full Text] [Related]
20. Etiology, cancer stem cells and potential diagnostic biomarkers for esophageal cancer.
Liu K; Zhao T; Wang J; Chen Y; Zhang R; Lan X; Que J
Cancer Lett; 2019 Aug; 458():21-28. PubMed ID: 31125642
[TBL] [Abstract] [Full Text] [Related]
[Next]
